{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:37:34Z","timestamp":1793407054700,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>The cholangioblastic variant of intrahepatic cholangiocarcinoma is a distinctive neoplasm that typically affects young women without underlying liver disease. Morphologically, it demonstrates solid, trabecular, and tubulocystic architecture, biphasic small cell-large cell cytology, and immunoreactivity for inhibin, neuroendocrine markers, and biliary but not hepatocellular markers. In 2021, our group identified a characteristic <jats:italic toggle=\"yes\">NIPBL::NACC1<\/jats:italic> gene fusion in cholangioblastic cholangiocarcinoma, and since then ~20 genetically confirmed cases have been reported in the literature. We report 2 additional cases, both of which caused diagnostic challenges. The first was previously published as a \u201cbiliary adenofibroma with malignant features\u201d which we now show recurred as a high-grade adenocarcinoma. Re-review of the original lesion demonstrated the morphologic and immunohistochemical features of highly cystic cholangioblastic cholangiocarcinoma, whereas the high-grade recurrence lacked many of these features. In addition to the characteristic <jats:italic toggle=\"yes\">NIPBL::NACC1<\/jats:italic> gene fusion, the recurrence demonstrated loss of the <jats:italic toggle=\"yes\">RB1<\/jats:italic> and <jats:italic toggle=\"yes\">PTEN<\/jats:italic> genes which were found in the highly cystic, bland areas of the original tumor, suggesting that the recurrence was derived from this bland component. The second case was originally misclassified as metastatic well-differentiated neuroendocrine neoplasm and only focally demonstrated the characteristic biphasic small cell-large cell cytology. In addition, a review of 7 cholangioblastic cholangiocarcinomas in our files demonstrates that loss of chromosome 13q14.2 (where the <jats:italic toggle=\"yes\">RB1<\/jats:italic> gene resides) and loss of chromosome 6q15-q16.3 are recurrent secondary changes in these neoplasms. Expression profiling demonstrated alterations in the transforming growth factor receptor beta superfamily, and overexpression of MYC which was validated by immunohistochemistry. Our findings expand the morphologic and genetic spectrum of this neoplasm and provide insight into secondary genetic changes associated with progression.<\/jats:p>","DOI":"10.1097\/pas.0000000000002365","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T01:00:10Z","timestamp":1736989210000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Cholangioblastic Cholangiocarcinoma (NIPBL::NACC1 Cholangiocarcinoma)"],"prefix":"10.1097","volume":"49","author":[{"given":"Pedram","family":"Argani","sequence":"first","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Anders","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul S.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munita","family":"Bal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rooper","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hicks","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Marzo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gagan","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Bioinformatics Core Facility, Lyda Hill Department of Bioinformatics, Department of Pathology University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen N.","family":"Palsgrove","sequence":"additional","affiliation":[{"name":"Bioinformatics Core Facility, Lyda Hill Department of Bioinformatics, Department of Pathology University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00428-005-1241-3","article-title":"Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives","volume":"446","author":"Vrettou","year":"2005","journal-title":"Virchows Arch"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humpath.2017.02.001","article-title":"Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibin A, a mimicker of neuroendocrine tumors: proposal to reclassify as \u201ccholangioblastic variant of intrahepatic cholangiocarcinoma","volume":"62","author":"Braxton","year":"2017","journal-title":"Hum Pathol"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2021.07.004","article-title":"Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma","volume":"116","author":"Wen","year":"2021","journal-title":"Hum Pathol"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/PAS.0000000000001729","article-title":"A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma","volume":"45","author":"Argani","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.21873\/anticanres.16052","article-title":"Molecular characteristics and immunogenomic profiling of cholangioblastic variant of intrahepatic cholangiocarcinoma in a 68-year-old patient","volume":"42","author":"Huang","year":"2022","journal-title":"Anticancer Res"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/10935266221119769","article-title":"Solid-tubulocystic variant of intrahepatic cholangiocarcinoma: report of a pediatric case with molecular characterization","volume":"25","author":"Gonz\u00e1lez","year":"2022","journal-title":"Pediatr Dev Pathol"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1177\/10668969231157775","article-title":"Inhibin-positive \u201cCholangioblastic\u201d variant of intrahepatic cholangiocarcinoma: report of 3 new patients with review of the literature","volume":"31","author":"Bakhshwin","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.dld.2023.05.006","article-title":"Cholangioblastic variant of intrahepatic cholangiocarcinoma: a recently described biliary cancer in young patients","volume":"55","author":"Marichez","year":"2023","journal-title":"Dig Liver Dis"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4132\/jptm.2022.04.07","article-title":"Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature","volume":"56","author":"Syrnioti","year":"2022","journal-title":"J Pathol Transl Med"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"e00746","DOI":"10.14309\/crj.0000000000000746","article-title":"A cholangioblastic variant of cholangiocarcinoma","volume":"9","author":"Verhoeff","year":"2022","journal-title":"ACG Case Rep J"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PAS.0000000000002159","article-title":"NIPBL::NACC1 fusion hepatic carcinoma","volume":"48","author":"Hissong","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.28818","article-title":"Biliary adenofibroma: a rare hepatic lesion with malignant features","volume":"65","author":"Kaminsky","year":"2017","journal-title":"Hepatology"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humpath.2022.06.001","article-title":"Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities","volume":"132","author":"Zen","year":"2023","journal-title":"Hum Pathol"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","article-title":"Pathologic classification of cholangiocarcinoma: new concepts","volume":"29","author":"Nakanuma","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","article-title":"Cholangiocarcinoma","volume":"11","author":"Krasinskas","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/PAS.0000000000002278","article-title":"Tubulocystic carcinoma of bile ducts: a distinct type of cholangiocarcinoma associated with adenofibroma-type lesions","volume":"48","author":"Masetto","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.humpath.2018.07.011","article-title":"Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs","volume":"82","author":"Cloutier","year":"2018","journal-title":"Hum Pathol"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PAS.0000000000000773","article-title":"Biliary adenofibroma of the liver: morphology, tumor genetics, and outcomes in 6 cases","volume":"41","author":"Arnason","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000478-199302000-00010","article-title":"Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver","volume":"17","author":"Tsui","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/his.15081","article-title":"Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality","volume":"84","author":"Na","year":"2024","journal-title":"Histopathology"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00432-024-05781-8","article-title":"Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies","volume":"150","author":"Gurzu","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"32620","DOI":"10.1074\/jbc.M402691200","article-title":"Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells","volume":"279","author":"Ammanamanchi","year":"2004","journal-title":"J Biol Chem"},{"key":"R28-20250722","first-page":"8331","article-title":"Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines","volume":"61","author":"Osada","year":"2001","journal-title":"Cancer Res"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1038\/onc.2017.51","article-title":"Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1\u03b1 axis","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/jid.2011.110","article-title":"Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells","volume":"131","author":"Tsunoda","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"eabo0183","DOI":"10.1126\/sciadv.abo0183","article-title":"NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance","volume":"8","author":"Yang","year":"2022","journal-title":"Sci Adv"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"47607","DOI":"10.18632\/oncotarget.17744","article-title":"Nac1 promotes self-renewal of embryonic stem cells through direct transcriptional regulation of c-Myc","volume":"8","author":"Ruan","year":"2017","journal-title":"Oncotarget"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/35036504","article-title":"A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins","volume":"407","author":"Lasorella","year":"2000","journal-title":"Nature"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1206055","article-title":"Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS\/ets protein in Ewing sarcoma","volume":"22","author":"Fukuma","year":"2003","journal-title":"Oncogene"},{"key":"R35-20250722","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1038\/sj.onc.1206025","article-title":"The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors","volume":"21","author":"Nishimori","year":"2002","journal-title":"Oncogene"},{"key":"R36-20250722","doi-asserted-by":"crossref","first-page":"e13773","DOI":"10.1111\/apha.13773","article-title":"ID2 controls differentiation of enteroendocrine cells in mouse small intestine","volume":"234","author":"Zinina","year":"2022","journal-title":"Acta Physiol (Oxf)"},{"key":"R37-20250722","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cancers16020392","article-title":"ID2 promotes lineage transition of prostate cancer through FGFR and JAK-STAT signaling","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R38-20250722","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12864-018-4828-1","article-title":"Landscape of transcriptional deregulation in lung cancer","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Genomics"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:00:31Z","timestamp":1753171231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002365"}},"subtitle":["Expanded Morphologic Spectrum and Further Genetic Characterization"],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002365","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}